Results 1 to 10 of about 47,271 (186)

Association between hyperhomocysteinemia and adverse obstetric outcome in patients with bad obstetric history [PDF]

New Indian Journal of OBGYN, 2021
Background: Hyperhomocysteinemia is a condition characterized by an abnormally high level of homocysteine in the blood conventionally described above 15μmol/l.
Saswati Sanyal Choudhury, Lokeshwari K, Gokul Chandra Das   +2 more
doaj   +1 more source

Expression profile of plasma microRNAs and target genes in patients with complicated pregnancy

Акушерство, гинекология и репродукция, 2023
Aim: to assess features of placental transcriptome in patients with complicated pregnancy course and outcome.Materials and Methods. A prospective observational comparative study in parallel groups was carried out by examining 44 patients divided into ...
M. D. Umerova, S. S. Alyadinova, M. J. Khonjonova, R. A. Balakadasheva, E. E. Menadzhiev, D. I. Kharchuk, D. O. Leus, G. I. Islyamova, M. I. Islyamova, S. L. Abkarimova, D. S. Kasabyan, L. E. Sorokina   +11 more
doaj   +3 more sources

Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia

Акушерство, гинекология и репродукция, 2022
Aim: to evaluate the effectiveness of using low molecular weight heparin (LMWH) and low-dose acetylsalicylic acid (ASA) in preventing recurrence of early and late fetal growth retardation (FGR) in patients with antiphospholipid syndrome (APS) and/or ...
E. A. Orudzhova, V. O. Bitsadze, M. V. Tretyakova, D. A. Doronicheva, F. Yakubova   +4 more
doaj   +1 more source

Non-invasive Maternal Hemodynamic Assessment to Classify High-Risk Pregnancies Complicated by Fetal Growth Restriction

Frontiers in Clinical Diabetes and Healthcare, 2022
ObjectivesTo verify whether the use of the temporal criterion of 32 weeks’ gestation is effective in identifying maternal hemodynamic differences between early- and late-onset fetal growth restriction (FGR), and to test the statistical performance of a ...
Sara Ornaghi, Sara Ornaghi, Andrea Caricati, Daniela Denis Di Martino, Martina Mossa, Sara Di Nicola, Sara Di Nicola, Francesca Invernizzi, Francesca Invernizzi, Sara Zullino, Sara Clemenza, Valentina Barbati, Gabriele Tinè, Federico Mecacci, Enrico Ferrazzi, Enrico Ferrazzi, Patrizia Vergani, Patrizia Vergani   +17 more
doaj   +1 more source

Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction. [PDF]

, 2020
The human placenta is a poorly-understood organ, but one that is critical for proper development and growth of the fetus in-utero. The epithelial cell type that contributes to primary placental functions is called "trophoblast," including two main ...
Farah, Omar, Nguyen, Calvin, Parast, Mana M, Tekkatte, Chandana   +3 more
core   +2 more sources

The Effects of Prenatal Pravastatin Treatment in the Rabbit Fetal Growth Restriction Model

Biomedicines, 2023
Fetal growth restriction (FGR) remains without an effective prenatal treatment. Evidence from murine FGR models suggests a beneficial effect of prenatal pravastatin.
Katerina Zapletalova, Ignacio Valenzuela, Marnel Greyling, Yannick Regin, Cristian Frigolett, Ladislav Krofta, Jan Deprest, Johannes van der Merwe   +7 more
doaj   +1 more source

Fetal growth restriction impairs hippocampal neurogenesis and cognition via Tet1 in offspring

Cell Reports, 2021
Summary: Fetal growth restriction (FGR) increases the risk for impaired cognitive function later in life. However, the precise mechanisms remain elusive.
Wen Chen, Nana Liu, Shijun Shen, Wei Zhu, Jing Qiao, Shujuan Chang, Jianfeng Dong, Mingliang Bai, Li Ma, Shanshan Wang, Wenwen Jia, Xudong Guo, Ang Li, Jiajie Xi, Cizhong Jiang, Jiuhong Kang   +15 more
doaj   +1 more source

Predicting fetal growth retardation: mathematical modeling

Акушерство, гинекология и репродукция, 2023
Introduction. Annually, more than 13 million neonates are born with fetal growth retardation (FGR) worldwide. FGR increases prenatal mortality and morbidity.
E. V. Kudryavtseva, V. V. Kovalev, A. A. Dektyarev, I. I. Baranov   +3 more
doaj   +1 more source

Thrombophilia in the pathogenesis of fetal growth retardation

Акушерство, гинекология и репродукция, 2021
Fetal growth retardation (FGR) is a complication of pregnancy that determines perinatal morbidity and mortality. It is a complex and multifaceted medical problem that does not lose its relevance.
E. A. Orudzhova, N. A. Samburova, E. V. Anichkova, K. E. Gotsiridze, V. O. Bitsadze   +4 more
doaj   +1 more source

Antiphospholipid antibodies, genetic thrombophilia and fetal growth retardation

Акушерство, гинекология и репродукция, 2022
Aim: to study the role of antiphospholipid antibodies (AРA) and genetic thrombophilia as a potential cause of the development or a component in the pathogenesis of early and late fetal growth retardation (FGR).Materials and Methods. There was conducted a
E. A. Orudzhova
doaj   +1 more source